The Journal of Immunology, Vol 148, Issue 3 672-677, Copyright © 1992 by American Association of Immunologists

ARTICLES

CD58 and CD59 molecules exhibit potentializing effects in T cell adhesion and activation

M Deckert, J Kubar and A Bernard
Institut National de la Sante et de la Recherche Medicale INSERM U343, Faculte de Medecine, France.

We have generated stable Chinese hamster ovary (CHO) cell transfectants expressing either CD58 or CD59 or both molecules to compare their respective parts played in T cell adhesion and activation. Using a rosetting assay, we have shown the following: 1) The CD59 molecule was directly responsible for adhesive interaction between human T cells and CD59+ CHO transfectants. CD59-mediated adhesion induced 12 +/- 2% (mean +/- SEM, n = 25) of rosettes. 2) The CD58 molecule expressed on CD58+ CHO transfectants induced 29 +/- 6% (mean +/- SEM, n = 8) of rosettes. 3) Double transfected CD58+CD59+ CHO cells formed up to 80% of rosettes, largely exceeding the sum of rosettes formed by single transfectants, thus disclosing at least an additive and possibly a synergic action of both molecules in mediating adhesion to T cells. Culturing purified human T cells in the presence of fixed CHO transfectants and submitogenic doses of PHA + rIL-1 alpha showed that: 1) CD59+ CHO transfectants induced sevenfold T cell proliferation enhancement, demonstrating the direct involvement of the CD59 molecule in T cell activation; 2) CD58+ CHO transfectants induced 20-fold T cell proliferation increase; and 3) the enhancement induced by CD58+CD59+ CHO cells was more than 40-fold. These results suggest that CD58 and CD59 molecules present on the surface of accessory cells might exert synergic function in T cell adhesive interactions and in the stimulation of T cell activation.

This article has been cited by other articles:

				M. Zeyda, A. B. Szekeres, M. D. Saemann, R. Geyeregger, H. Stockinger, G. J. Zlabinger, W. Waldhausl, and T. M. Stulnig Suppression of T Cell Signaling by Polyunsaturated Fatty Acids: Selectivity in Inhibition of Mitogen-Activated Protein Kinase and Nuclear Factor Activation J. Immunol., June 15, 2003; 170(12): 6033 - 6039. [Abstract] [Full Text] [PDF]

				N. Kanuga, H. L. Winton, L. Beauchene, A. Koman, A. Zerbib, S. Halford, P.-O. Couraud, D. Keegan, P. Coffey, R. D. Lund, et al. Characterization of Genetically Modified Human Retinal Pigment Epithelial Cells Developed for In Vitro and Transplantation Studies Invest. Ophthalmol. Vis. Sci., February 1, 2002; 43(2): 546 - 555. [Abstract] [Full Text] [PDF]

				J. Ludemann, K.-L. Schulte, O. Hader, S. Brehme, H.-D. Volk, and W.-D. Docke Leukocyte/Endothelium Activation and Interactions During Femoral Percutaneous Transluminal Angioplasty Vascular and Endovascular Surgery, July 1, 2001; 35(4): 293 - 301. [Abstract] [PDF]

				W. Hahn, E Menu, A. Bothwell, P. Sims, and B. Bierer Overlapping but nonidentical binding sites on CD2 for CD58 and a second ligand CD59 Science, June 26, 1992; 256(5065): 1805 - 1807. [Abstract] [PDF]